1859EGP
- Active ingredient
- netupitant+palonosetron
- Strength
- 300/0.5 mg
- Form
- capsule
- Manufacturer
- helsinn > mundipharma
- Route
- oral.solid
Uses
Used for prevention of acute and delayed nausea and vomiting associated with cancer chemotherapy.
Do not use if
Hypersensitivity to netupitant, palonosetron, or formulation components.
Side effects
Headache, constipation, fatigue, or dyspepsia may occur.
Warnings
Use cautiously with medicines affecting serotonin pathways.
How it works
Combines an NK1 receptor antagonist with a 5-HT3 receptor antagonist to prevent chemotherapy-induced nausea and vomiting.
Storage
Store at room temperature.